1.	Please file a revised Exhibit (a)(3) of the Registration Statement (the legality opinion) to include a consent of counsel to discuss the legality opinion in the Prospectus. See Rule 436(a) under the Securities Act of 1933 and Footnote 50 to Staff Legal Bulletin No. 19.

2.	Please confirm to the Staff that (i) the principal risks and investment strategies of the Fund’s wholly owned subsidiary that are also principal risks and investment strategies of the Fund are disclosed in the Prospectus, and (ii) the principal investment strategies and risks of the Fund disclosed in the Prospectus reflect the aggregate operations of the Fund and its wholly owned subsidiary.

---

3.	Please confirm to the Staff whether the Fund will impose any mandatory arbitration provisions on shareholders in its Registration Statement or any exhibits thereto.

4.

Article X, Section 11 of the Fund’s Amended and Restated Declaration of Trust (Exhibit (a)(3) to the Registration Statement) (the “Declaration of Trust”) contains an exclusive jurisdiction provision. Please add prominent, plain English disclosure to the Prospectus that explains the exclusive jurisdiction provision, including (i) the relevant forum for litigation and (ii) the application of the provision to claims under the federal securities laws. The disclosure should address any uncertainty about enforceability of the provision and state that investors cannot waive compliance with the federal securities laws and the rules and regulations promulgated thereunder. Please also include prominent risk disclosure describing any other risks or effects that this exclusive jurisdiction provision has on investors.

5.

Article X, Section 11 of the Declaration of Trust also contains a jury trial waiver provision. Please add prominent, plain English disclosure to the Prospectus that explains the provision and indicates whether or not the provision extends to claims under the federal securities laws. The disclosure should address any uncertainty about enforceability of the provision and the effect or impact it would have on claims arising under other laws. Please also ensure that the provision’s risks or other effects on shareholders are prominently disclosed, and disclose that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.

6.	Please supplementally advise the Staff if exclusive jurisdiction or waiver of jury trial provisions appear in any other documents that are filed as exhibits to the Registration Statement aside from the Declaration of Trust.

7.

We note that significant market events as a result of the coronavirus have occurred since the Registration Statement was filed. Please consider whether the Fund’s disclosure, including its risk disclosure, should be revised based on how these events are affecting the market (including the market for floating-rate investments, to the extent applicable). If the Fund believes that no additional disclosure is warranted, please explain to the Staff supplementally why not.

---

8.	Please consider whether, under current market conditions, it may take longer than 3 months to invest the proceeds of the Fund’s offering. If Fund expects a delay, please disclose the reasons for such delay and add corresponding risk disclosure. See Guide 1 to Form N-2.